Cenobamate — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-08 (month) in 1mo
ESTIMATED |
READOUT
Cenobamate Open-Label Extension Study for YKP3089C025
Phase 3 · Primary Generalized Tonic Clonic Seizures in the Setting of Idiopathic Generalized Epilepsy |
SK Life Science, Inc. | Cenobamate |
ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
|